Cardiovascular Disease Risk of Awareness

Cardiovascular Diseases Clinical Trial

Official title:

The Effect on Risk Awareness, Perception and Risk Factors of Motivational Interview-Based Cardiovascular Risk Reduction Program (CARDIOREP) in Taxi-Minibus Drivers: A Randomized Controlled Research

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06000436
• Other study ID #: NecmettinEU70
• Status: Not yet recruiting
• Phase: N/A
• Start date: November 2023
• Est. completion date: March 2024

Study information

• Verified date: November 2023
• Source: Necmettin Erbakan University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The Cardiovascular Risk Reduction Program (CARDIOREP) aims to raise risk awareness and reduce risk factors.

Description:

While 1/3 of premature deaths in individuals under the age of 70 in the world occur due to Cardiovascular Diseases (WHO 2022), circulatory system diseases are at the forefront with 36.76% according to the health statistics of the Ministry of Health in our country. It is necessary to raise awareness and gain healthy lifestyle behaviors in the prevention of cardiovascular diseases. The Cardiovascular Risk Reduction Program (CARDIOREP) aims to raise risk awareness and reduce risk factors.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 54
• Est. completion date: March 2024
• Est. primary completion date: December 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Not having been diagnosed with cardiovascular disease.

• Using a smartphone.

• Agree to use the Google Fit App.

Exclusion Criteria:

Related Conditions & MeSH terms

• Cardiovascular Diseases

Intervention

Other:
• Cardiovascular disease risk assessment
Cardiovascular disease risk assessment Training and Consultancy Based on the literature, the researcher prepared a Training Guide for the Prevention of Cardiovascular Diseases, including the subjects of Cardiovascular Diseases and Risk Factors, Physical Activity, Smoking and Heart Health, BMI and Heart Health, Nutrition, and Stress. By using the training guide, training time for individual training intervention will be planned for one day of the week with the participants. Individual training will last 30 minutes at the stops with waiting areas during the working hours of the participants. Mobile Application To the participants in the intervention group 2, 4. In the 6th and 6th weeks, text messages will be shared once a week to increase motivation and prevent cardiovascular diseases. Monitoring Daily data from the previous week (cardio score, number of steps) will be taken from the Google Fit application.
• Training and Consultancy
Based on the literature, the researcher prepared a Training Guide for the Prevention of Cardiovascular Diseases, including the subjects of Cardiovascular Diseases and Risk Factors, Physical Activity, Smoking and Heart Health, BMI and Heart Health, Nutrition, and Stress. Using the training guide, training time for individual training intervention will be planned for one day of the week with the participants. Individual training will last 30 minutes at the stops with waiting areas during the participants' working hours.
• Mobile Application
To the participants in the intervention group 2, 4. In the 6th and 6th weeks, text messages will be shared once a week to increase motivation and prevent cardiovascular diseases. Text Messages Week 2 "Tobacco use causes 6 million deaths in the world. The risk of death is reduced by 90% in those who stop using tobacco. Alcohol use causes damage to the heart muscle, arrhythmia, and stroke. For a healthy life, you should stay away from smoking and alcohol. ' Week 4 '' Inadequate physical activity increases the risk of death from all causes. Physical activity reduces the risk of hypertension, stroke, and depression. 30 minutes of moderate-intensity physical activity daily is recommended. Week 6 "Adequate consumption of vegetables and fruits reduces the risk of cardiovascular disease. Saturated and trans fats increase the risk of cardiovascular disease. It is recommended to consume <5 g less per day to prevent cardiovascular diseases.
• Monitoring
Daily data from the previous week (cardio score, number of steps) will be taken from the Google Fit application.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Necmettin Erbakan University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cardiovascular Disease Risk Awareness Rating Scale Scores	The scale form consists of 3 sub-dimensions and 21 items. The sub-dimensions consist of perceived heart attack and stroke risk, healthy eating intentions, perceived benefits and intentions to change. A maximum score of 64 and a minimum score of 0 can be obtained from the scale. A higher score on the scale and its sub-dimensions indicates an increased awareness of cardiovascular diseases.	at the end of 0th, 6th, and 12th weeks
Secondary	Cardiovascular risk perception	Perceived cardiovascular disease risk in the next 10 years is questioned as low, moderate, high and very high.	at the end of 0th, 6th, and 12th weeks
Secondary	International Physical Activity Questionnaire Scores	The international physical activity questionnaire (Short Form) consists of 7 questions. The questionnaire asks about the number of days of vigorous, moderate, mild physical activity in the last 7 days and how much of the day, and how much time is spent sitting in individuals who do not engage in physical activity. It provides the calculation of the energy expended by the activities in meters. A high score on the scale form indicates being active in physical activity.	at the end of 0th, 6th, and 12th weeks
Secondary	Beck Anxiety Scale Scores	The scale form consists of 21 questions on a 4-point Likert scale (0=none, 3=seriously) about anxiety symptoms in the last one week.	at the end of 0th, 6th, and 12th weeks
Secondary	Cardiovascular disease risk factors	anthropometric measurements weight (Kilograms)	at the end of 0th, 6th, and 12th weeks
Secondary	Cardiovascular disease risk factors	anthropometric measurements height (meter)	at the end of 0th, 6th, and 12th weeks
Secondary	Cardiovascular disease risk factors	anthropometric measurements hip circumference (centimeters)	at the end of 0th, 6th, and 12th weeks
Secondary	Cardiovascular disease risk factors	anthropometric measurements waist circumference (centimeters)	at the end of 0th, 6th, and 12th weeks
Secondary	Cardiovascular disease risk factors	blood pressure (mmHg)	at the end of 0th, 6th, and 12th weeks